After the government announced new regulations for Medicare Advantage, the market-based alternative to traditional Medicare, the stocks of healthcare companies that participate in the program plummeted. But why is this popular program in the crosshairs? And are these new Trump Administration rules actually...good?
Today on the show, Olivia Kosloff, senior fellow at the American Economic Liberties Project and creator of the newsletter Acute Condition, joins Matt and David to discuss Medicare Advantage and how a program that was intended to be cheaper for the government than traditional Medicare has become far more expensive. In addition to problems that have plagued the program since its inception, AI is now being used as a new tool for insurers to extract money from the government. They also discuss how insurers are reacting to the new rules, the future of the program, and whether we need Medicare Advantage at all.
